Molecular Partners AG / Fundamentals
Income statement
- Net revenue
€737.81K - Cost of goods sold
€599.13K - Gross profit
€138.68K - SG&A expenses
€17.82M - R&D expenses
€47.71M - EBITDA
-€67.73M - D&A
€2.46M - EBIT
-€68.08M - Interest expenses
€36.84K - EBT
-€70.21M - Tax expenses
€0.00 - Net income
-€70.21M
Cash flow statement
- Net deferred tax
-€2.17K - Non-cash items
-€288.19K - Changes in working capital
€1.79M - Operating cash flow
-€61.38M - Capex
€1.02M - Other investing cash flow
€2.91M - Net investing cash flow
€64.64M - Total cash dividends paid
€0.00 - Issuance of common stock
€68.26K - Debt repayment
-€1.31M - Other financing cash flow
€16.91M - Net financing cash flow
€15.66M - Foreign exchange effects
-€1.27M - Net change in cash
€17.65M - Cash at end of period
€88.81M - Free cash flow
-€60.37M
Balance sheet
- Cash and cash equivalents
€88.81M - Cash and short-term investments
€124.04M - Total receivables
€3.91M - Inventory
€0.00 - Other current assets
€2.68M - Total current assets
€130.63M - Property, plant & equipment
€3.98M - Goodwill
€0.00 - Intangible assets
€10.83K - Long-term investments
€0.00 - Other non-current assets
€0.00 - Total non-current assets
€3.99M - Total assets
€134.62M - Accounts payable
€2.14M - Short-term debt
€2.65M - Other current liabilities
€9.19M - Total current liabilities
€13.97M - Long-term debt
€666.31K - Deferred tax liabilities
€0.00 - Other non-current liabilities
€4.42M - Total non-current liabilities
€5.09M - Total liabilities
€19.06M - Common stock
€4.37M - Retained earnings
-€307.02M - Other equity
€0.00 - Total equity
€115.56M - Total liabilities and shareholders' equity
€134.62M
Company information
- Market capitalization
€116.82M - Employees
158 - Enterprise Value
€53.62M
Company ratios
- Gross margin
-
18.8% Much better than peer group: -79.7% - EBITDA margin
-
-9,179.3% Much worse than peer group: -1,524.8% - EBIT margin
-
-9,227.9% Much worse than peer group: -2,938.9% - EBT margin
-
-9,516.0% Much worse than peer group: -3,006.7% - Net margin
-
-9,516.2% Much worse than peer group: -3,095.0% - ROE
-
-60.8% Much better than peer group: -410.3% - ROA
-
-52.2% Much better than peer group: -176.0% - Asset turnover
-
0.5% Much worse than peer group: 39.5% - FCF margin
-
-8,457.6% Much worse than peer group: -1,356.3% - FCF yield
-53.4% - Efficiency ratio
9,279.3% - Net sales per employee
-
€4.67K - Net income per employee
-
-€444.38K